GlucoTrack, Inc. (GCTK)
NASDAQ · Healthcare
$0.41-16.87%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $279.19K
- P/E ratio
- —
- EPS
- —
- Volume
- 1,801,309
- 52-week high
- —
- 52-week low
- —
- Open
- $0.43
- Day high
- $0.46
- Day low
- $0.38
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$19.39M | $31.22 |
| 2024 | — | -$22.6M | $4,106.00 |
| 2023 | — | -$7.1M | $34.18 |
| 2022 | — | -$4.44M | $0.29 |
| 2021 | — | -$4.07M | $0.26 |
About GlucoTrack, Inc.
Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.
- CEO
- Paul V. Goode
- Employees
- 15
- Country
- US
- IPO date
- Apr 25, 2013
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is GlucoTrack, Inc.'s stock price today?
- GCTK is trading at $0.41 as of Jul 20, 2026.
- What is GlucoTrack, Inc.'s market cap?
- GlucoTrack, Inc. (GCTK) has a market capitalization of $279.19K.
- Does GlucoTrack, Inc. pay a dividend?
- GlucoTrack, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is GlucoTrack, Inc. in?
- GlucoTrack, Inc. operates in the Healthcare sector.